About

We are a biotechnology company that creates high-performance proteins from limited experimental data using our proprietary aiProtein® technology.

About Us

Technology

Transforming ‘Uncertainty’
into ‘Certainty’

(01)

A revolutionary protein design platform that
integrates AI with directed evolution

By combining AI-driven predictions with laboratory data, we dramatically expand the possibilities of protein design. With a proven track record of replicating 30 years of research in just 7 days, our technology supports a wide range of proteins including antibodies and enzymes—solving the challenges of speed and cost in R&D.

aiProtein®

Case Studies

Collaboration Track Record with Major Domestic and International Companies and Research Institutions
RevolKa's technology is utilized across diverse industries

We deliver solutions to protein development challenges, primarily for pharmaceutical and biotechnology companies in Japan and abroad, contributing to dramatic improvements in R&D efficiency.

Case Studies

Business

We are developing proprietary drug discovery and partnership businesses centered on aiProtein® technology

aiProtein®

Pharmaceutical Business

Development of mRNA therapeutics
using enzymes enhanced by aiProtein®

Partnership Business

Optimization of diverse needs from
companies and research institutions
working with proteins through aiProtein®

For Investors

From Japan to the World—Becoming a
Bio-AI Company That Changes the World

We are leading Japan’s biotech industry and growing into a company that can compete in the global market.
We welcome investors who want to join us in taking on the next stage of this challenge.

For Investors

Latest News

  • ALL
  • news
  • event
  • collab
  • corporate

Read more